Blaize Holdings faces a federal securities class action alleging it inflated revenue through transactions with counterparties unequipped to conduct real business, with an October 5 lead plaintiff deadline approaching.
Faruqi & Faruqi partner James (Josh) Wilson encouraged investors who purchased Blaize securities between July 18, 2025 and April 28, 2026 to contact the firm to discuss their legal rights, according to the law firm's announcement.
The complaint alleges Blaize announced deals with entities wholly unequipped to conduct meaningful business to create an appearance of growth and improperly recognized revenue. On April 28, Pelican Way Research published a report alleging Blaize artificially boosted its share price through a deal with NeoTensr, a counterparty incorporated in late December 2025 with roughly $2 million in startup capital. The report questioned how Blaize recognized $20 million in revenue from a NeoTensr order in Q4 2025. Blaize shares fell $0.26, or 12.03 percent, to close at $1.90 that day.
Investors seeking lead plaintiff status must file motions with the court by October 5, 2026. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought who is adequate and typical of class members. Class members who do not seek the role can still share in any recovery, and eligibility is not limited to those who pursue appointment.
The lawsuit covers all persons and entities other than defendants who purchased or otherwise acquired publicly traded Blaize securities during the class period. Faruqi & Faruqi also encouraged anyone with information regarding Blaize's conduct to contact the firm, including whistleblowers, former employees and shareholders.
The allegations raise governance questions for Blaize, an AI-focused company listed on the Nasdaq. The October 5 deadline will determine who directs the litigation, and any settlement or judgment could carry material financial consequences for the company. Investors will watch for further disclosures from Blaize and the court's handling of lead plaintiff motions in the coming weeks.
This article is for informational purposes only and does not constitute investment advice.